Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Hosts 5th CRISPR Virtual Event on November 2nd, 2022
  • USA - English


News provided by

Labroots

Oct 27, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

CRISPR, November 2, 2022
CRISPR, November 2, 2022

The global meeting will focus on CRISPR-Cas systems, genetic engineering technologies, novel approaches to cell and gene therapy, and emerging discoveries pushing the boundaries of CRISPR research

YORBA LINDA, Calif., Oct. 27, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is delighted to announce its 5th annual CRISPR virtual event. The free, online event builds on previous years events and advances the conversations happening around sessions such as CRISPR Biology, CRISPR in Diagnostics, and CRISPR in Disease Therapy. This event will take place on November 2, 2022.

CRISPR 2022 promises to bring together thought leaders from academia, research scholars, top scientists, and industry experts from pharmaceutics and biotech from around the world to uncover promising approaches and advances in the field.

The educational agenda featuring distinguished speakers will showcase cutting-edge research in the discovery of new CRISPR-Cas systems, gene editing therapies, and other applications. Topics for discussion include key requirements of CRISPR reagents for preclinical and translational research, current and novel approaches to targeted gene editing, new molecular technologies for genome editing and cell control, innovative tools for efficient CRISPR-Cas genome engineering, CRISPR-based microfluidic biosensing systems for molecular diagnostics, detecting viruses with CRISPR, and so much more!

"The pandemic inspired our community to come together and harness our collective talents to create new classes of diagnostics and therapeutics for detecting and treating pathogens," commented Planning Committee Member, James. J. Collins and Termeer Professor of Medical Engineering & Science, and Professor of Biological Engineering, MIT. "These innovative efforts brilliantly leveraged conceptual and technical advances in synthetic biology and CRISPR-based technologies, and we aim to highlight these successes in this timely conference."

Key highlights encompass a keynote presentation discussing the mechanism of CRISPR-Cas13 systems and the engineering methods for nucleic acid detection, presented by Dr. Xue Sherry Gao, Ted N. Law Assistant Professor, Department of Chemical and Biomolecular Engineering at Rice University, followed by Dr. Can Dincer, Junior Research Group Leader, University of Freiburg, Department of Microsytems Engineering-IMTEK summarizing the fundamentals of CRISPR-powered biosensing during his keynote delivery titled, 'CRISPR-Powered Multiplexed Biosensor for Point-of-Care Management of Infectious Diseases' with Live Q&A.

"We've been working to design and engineer new platforms for viral detection since the COVID-19 pandemic started," said Dr. Xue Sherry Gao, Assistant Professor in the Department of Chemical and Biomolecular Engineering at Rice. "Our focus is on platforms that can be used in low-resource setting areas when expensive PCR machines are not available. I would like to share with the audience our work on the identification of a flexible hairpin loop near CRISPR-Cas13's active site. By inserting an RNA binding domain into that unique loop, greatly enhanced the activity of the Cas13 activity in detecting various viruses, including SARS-CoV-2. By coupling with an electrochemical sensor, our engineered Cas13 protein showed attomolar levels of activity without pre-amplification and complex handling of the viral samples."

"Over last few years, we have witnessed great innovations and advances in the field of nucleic acid diagnostics driven by the unique features of the CRISPR/Cas technology," said Dr. Can Dincer, Junior Research Group Leader at FIT & IMTEK, University of Freiburg. "In this keynote presentation, a CRISPR-powered multiplexed biosensing system capable of not only simultaneously detecting nucleic acids but also other molecules like drugs will be presented, as well as the current challenges and future perspectives of CRISPR-based biosensing will be discussed. I'm excited to share our research via Labroots' unique virtual platform."

"Our annual CRISPR virtual event has been a benchmark in the field and continues to highlight creative new CRISPR technologies and further progress genome engineering revolutionizing biological research while making groundbreaking inroads to therapies," said Greg Cruikshank, Chief Executive Officer of Labroots. "We are delighted to host and produce this event for the scientific community to stay up to date on novel research and global trends in CRISPR biology."

Produced on Labroots' robust platform allowing the capability to connect seamlessly across all desktops and mobile devices, the interactive environment delivers a one-stop educational experience. Attendees will visit the lobby with leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall to interact with sponsors and view their products and technologies, a poster hall to explore data and engage in live chat conversations, and featuring a poster competition to give your research a competitive edge, and a networking lounge to make valuable connections with colleagues. By participating, there is a potential to earn up to 1 P.A.C.E. Continuing Education credit per presentation for a maximum of 30 credits.

To register for the event, click here. Join the online conversation and use the hashtag #LRcrispr. Follow @Genetics_LR on Twitter and @GeneticsandGenomics on Facebook to connect with our specialist Genetics & Genomics Writers and stay up to date with the latest Trending News in Genetics & Genomics. Now you can also join our professional community on LinkedIn by being a part of the Genetics & Genomics group!

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.